Orient Paper Q1 Results: Net Loss Narrows To ₹8.25 Crore
Orient Paper & Industries Ltd reported a Q1FY26 net loss of ₹8.25 crore, improving from a prior-year profit driven by one-time tax credits. Revenue fell 4.5% YoY to ₹2,276 crore. The board appointed Anuradha Mookerjee as independent director.

*this image is generated using AI for illustrative purposes only.
Orient Paper & Industries reported a net loss of ₹8.25 crore for the quarter ended June 30, 2026, narrowing significantly from the ₹34 crore profit recorded in the corresponding quarter of the previous year. The company’s revenue from operations fell to ₹2,276.14 crore, down from ₹2,383.44 crore in Q1FY25. The Board of Directors approved the unaudited financial results on August 7, 2026, alongside key governance changes including the appointment of a new independent director.
The financial statement was reviewed by B S R & Co. LLP, the statutory auditors, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board also approved the appointment of Mrs. Anuradha Mookerjee as an Additional Director in the category of Independent Director, effective August 8, 2026, subject to shareholder approval. Concurrently, Mrs. Gauri Rasgotra will cease to be an Independent Director upon completing her second consecutive term on August 21, 2026.
Financial Performance
Revenue from operations declined by approximately 4.5% year-on-year to ₹2,276.14 crore in Q1FY26, compared to ₹2,383.44 crore in Q1FY25. Other income stood at ₹23.95 crore, contributing to a total income of ₹2,300.09 crore. Total expenses decreased to ₹2,408.75 crore from ₹2,589.77 crore in the prior year period, driven largely by lower material costs and other expenses.
| Particulars | Q1FY26 (₹ Cr) | Q1FY25 (₹ Cr) | Change |
|---|---|---|---|
| Revenue from Operations | 2,276.14 | 2,383.44 | -4.5% |
| Other Income | 23.95 | 27.87 | -14.1% |
| Total Expenses | 2,408.75 | 2,589.77 | -7.0% |
| Loss Before Tax | (108.67) | (178.47) | Improved |
| Net Profit / (Loss) | (82.50) | 339.93 | Turnaround |
The company incurred a loss before tax of ₹108.67 crore, an improvement from the ₹178.47 crore loss in Q1FY25. Tax expenses included a deferred tax credit of ₹26.16 crore. In the prior year, the significant profit was partly driven by a one-time deferred tax credit of ₹518.40 crore related to the option exercised under Section 115BAA of the Income-tax Act, 1961.
Segment Analysis
The paper & tissue segment, which constitutes the majority of the business, saw revenue decline to ₹1,867.50 crore from ₹1,952.26 crore in Q1FY25. This segment reported a loss of ₹42.15 crore, compared to a loss of ₹93.46 crore in the same period last year, indicating operational improvement despite lower sales. The chemicals segment generated revenue of ₹442.88 crore, slightly down from ₹465.77 crore, but remained profitable with a segment result of ₹61.04 crore.
| Segment | Revenue Q1FY26 (₹ Cr) | Result Q1FY26 (₹ Cr) |
|---|---|---|
| Paper & Tissue | 1,867.50 | (42.15) |
| Chemicals | 442.88 | 61.04 |
Total assets stood at ₹22,054.19 crore, while total liabilities were ₹7,247.70 crore as of June 30, 2026. The unallocated assets comprised ₹8,068.53 crore, reflecting corporate-level holdings and investments.
What the Numbers Show
The narrowing of the net loss is primarily attributable to improved operational efficiency in the paper & tissue segment, where the loss reduced by over 50% year-on-year despite a decline in revenue. The absence of the large one-time deferred tax credit seen in Q1FY25 makes the current quarter's performance a more accurate reflection of ongoing operations. While revenue pressures persist across both segments, the reduction in total expenses suggests cost-control measures are yielding results.
Historical Stock Returns for Orient Paper & Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.70% | +6.50% | +9.33% | -10.32% | -33.54% | -40.29% |
How will the appointment of Mrs. Anuradha Mookerjee as an independent director influence the company's strategic direction for turning the paper & tissue segment profitable?
Given the 4.5% revenue decline, what specific pricing or volume strategies is Orient Paper planning to implement in Q2FY26 to reverse the top-line contraction?
Will the cost-control measures that reduced total expenses by 7% be sustainable in the long term without impacting product quality or market share?


































